https://www.medscape.com/viewarticle/983907
0
0
11/11/22 at 2:50pm
Organization
Medscape
37 words
0
Comments
In patients with type 2 diabetes and peripheral artery disease who undergo revascularization, cardiovascular and renal benefits of the agents were confirmed without increased risk of limb amputation.
You are the first to view
Create an account
or login to join the discussion